ArticleCancer immunology, immunotherapy : CII2025

Generation of frameshift-mutated TGFβR2-specific T cells in healthy subjects following administration with cancer vaccine candidate FMPV-1/GM-CSF in a phase 1 study.

Else Marit Inderberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.